United-Guardian, Inc.
United-Guardian, Inc. (Nasdaq: UG) manufactures and develops specialty cosmetic, personal care and sexual wellness ingredients, pharmaceuticals, and medical lubricants through its Guardian Laboratories division. It operates as a single business segment with four product categories: cosmetic ingredients, medical… From the company’s description.
Over the twelve months to Jun 30, 2026, United-Guardian, Inc. reported revenue of $11.21M, up 3.2% from a year earlier, and net income of $2.46M. Its operating margin was 20.8%, and operations generated $3.47M in cash. In fiscal 2025, it reported revenue of $10.55M, down 13.4% from fiscal 2024, and net income of $2.11M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What United-Guardian, Inc. does
In the company’s own words
United-Guardian, Inc. (Nasdaq: UG) manufactures and develops specialty cosmetic, personal care and sexual wellness ingredients, pharmaceuticals, and medical lubricants through its Guardian Laboratories division. It operates as a single business segment with four product categories: cosmetic ingredients, medical lubricants, pharmaceuticals and sexual wellness ingredients. In 2025, pharmaceuticals accounted for 51% of sales, cosmetic ingredients 29%, and medical lubricants 20%; sexual wellness products had no sales that year. Its Lubrajel hydrogels serve personal care formulations such as moisturizers and sunscreens, as well as medical products including catheters and surgical instruments. Renacidin, an FDA-approved prescription drug, is used mainly to prevent and dissolve catheter calcifications, while Clorpactin is a chlorine-based topical antimicrobial. The company sells cosmetic ingredients through five distributors to personal care product formulators and manufacturers, pharmaceuticals mainly through drug wholesalers, and medical lubricants directly to medical product marketers and manufacturers. It reported 2025 revenue of approximately $9.7 million and had 25 employees. The business traces its origins to United International Research, founded in 1942; United-Guardian adopted its current name after a 1982 merger. Its website is www.u-g.com.
Company details
- Sector
- Materials
- Industry (SIC)
- Personal Care
- Headquarters
- HAUPPAUGE, NY
- Fiscal year end
- December
- CIK
- 101295
- SIC
- 2844
Financial performance, year by year
Fiscal 2011–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns United-Guardian, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · United-Guardian, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do United-Guardian, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of United-Guardian, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in United-Guardian, Inc.'s last four quarterly filings that the numbers alone won't show?”